IceCure Medical Ltd (ICCM)
USD 1.14
(-7.67%)
USD 1.14
(-7.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -9.93 Million USD | 56.92% |
| 2022 | -23.06 Million USD | 6.68% |
| 2021 | -24.71 Million USD | -672.08% |
| 2020 | -3.2 Million ILS | 42.15% |
| 2019 | -5.53 Million ILS | -31.94% |
| 2018 | -4.19 Million ILS | -704.77% |
| 2017 | -521.06 Thousand ILS | 81.5% |
| 2016 | -2.81 Million ILS | 37.65% |
| 2015 | -4.51 Million ILS | -73.45% |
| 2014 | -2.6 Million ILS | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -9.1 Million USD | 11.53% |
| 2024 Q1 | -10.32 Million USD | -4.78% |
| 2023 Q4 | -9.85 Million USD | -205.39% |
| 2023 FY | -9.93 Million USD | 56.92% |
| 2023 Q2 | -2.42 Million USD | 52.04% |
| 2023 Q1 | -5.05 Million USD | 78.09% |
| 2023 Q3 | -3.22 Million USD | -33.09% |
| 2022 Q1 | -21.5 Million USD | 12.97% |
| 2022 FY | -23.06 Million USD | 6.68% |
| 2022 Q3 | -11.77 Million USD | 7.55% |
| 2022 Q4 | -23.06 Million USD | -95.94% |
| 2022 Q2 | -12.73 Million USD | 40.81% |
| 2021 FY | -24.71 Million USD | -672.08% |
| 2021 Q3 | -46.96 Million USD | 22.22% |
| 2021 Q4 | -24.71 Million USD | 47.39% |
| 2021 Q2 | -60.38 Million USD | -321.02% |
| 2021 Q1 | 27.32 Million USD | 953.63% |
| 2020 Q3 | 16.57 Million USD | 463.84% |
| 2020 Q4 | -3.2 Million ILS | -119.31% |
| 2020 FY | -3.2 Million ILS | 42.15% |
| 2020 Q1 | -16.21 Million USD | -193.07% |
| 2020 Q2 | -4.55 Million ILS | 71.91% |
| 2019 Q4 | -5.53 Million ILS | 71.81% |
| 2019 FY | -5.53 Million ILS | -31.94% |
| 2019 Q1 | -10.99 Million USD | -162.3% |
| 2019 Q2 | -2.94 Million ILS | 73.19% |
| 2019 Q3 | -19.62 Million USD | -565.59% |
| 2018 Q4 | -4.19 Million ILS | 78.32% |
| 2018 Q2 | -6.19 Million ILS | 72.66% |
| 2018 Q1 | -22.68 Million USD | -4252.66% |
| 2018 Q3 | -19.34 Million USD | -212.04% |
| 2018 FY | -4.19 Million ILS | -704.77% |
| 2017 FY | -521.06 Thousand ILS | 81.5% |
| 2017 Q1 | -6.45 Million USD | -129.22% |
| 2017 Q4 | -521.06 Thousand ILS | 88.08% |
| 2017 Q2 | -1.85 Million ILS | 71.33% |
| 2017 Q3 | -4.37 Million USD | -136.19% |
| 2016 Q3 | -3.66 Million USD | -36.66% |
| 2016 Q4 | -2.81 Million ILS | 23.22% |
| 2016 FY | -2.81 Million ILS | 37.65% |
| 2016 Q2 | -2.68 Million USD | 27.43% |
| 2016 Q1 | -3.69 Million USD | 18.33% |
| 2015 FY | -4.51 Million ILS | -73.45% |
| 2015 Q3 | -5.38 Million USD | 17.27% |
| 2015 Q2 | -6.5 Million USD | 0.91% |
| 2015 Q1 | -6.56 Million USD | 34.06% |
| 2015 Q4 | -4.52 Million USD | 15.84% |
| 2014 FY | -2.6 Million ILS | 0.0% |
| 2014 Q4 | -9.95 Million USD | -2.2% |
| 2014 Q3 | -9.74 Million USD | 24.94% |
| 2014 Q2 | -12.97 Million USD | 22.17% |
| 2014 Q1 | -16.67 Million USD | 15.79% |
| 2013 Q1 | -5.66 Million USD | -14.23% |
| 2013 Q2 | -9.93 Million USD | -75.26% |
| 2013 Q3 | -23.57 Million USD | -137.43% |
| 2013 Q4 | -19.8 Million USD | 16.0% |
| 2012 Q4 | -4.96 Million USD | 45.92% |
| 2012 Q3 | -9.17 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 136.681% |
| BrainsWay Ltd. | -10.32 Million USD | 3.74% |
| Cerus Corporation | 84.35 Million USD | 111.777% |
| Envoy Medical, Inc. | -3.81 Million USD | -160.461% |
| electroCore, Inc. | -9.95 Million USD | 0.211% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -93.834% |
| Inogen, Inc. | -103.56 Million USD | 90.408% |
| OrthoPediatrics Corp. | -9.26 Million USD | -7.198% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -172.837% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 24.151% |
| MaxCyte, Inc. | -27.76 Million USD | 64.219% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -93.34% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1625.351% |
| Orthofix Medical Inc. | 96.44 Million USD | 110.3% |
| PAVmed Inc | 29.08 Million USD | 134.154% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 41.354% |
| RxSight, Inc. | -6.68 Million USD | -48.713% |
| Sight Sciences, Inc. | -102.71 Million USD | 90.329% |
| SI-BONE, Inc. | 5.72 Million USD | 273.641% |
| TELA Bio, Inc. | -3.94 Million USD | -151.557% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 117.33% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 2922.159% |
| Acutus Medical, Inc. | 12.27 Million USD | 180.902% |
| Talis Biomedical Corporation | -57.06 Million USD | 82.591% |
| Spectral AI, Inc. | -3.5 Million USD | -183.748% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 79.316% |
| CVRx, Inc. | -59.95 Million USD | 83.431% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 600.669% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 877.529% |
| Bioventus Inc. | 372.51 Million USD | 102.667% |
| Venus Concept Inc. | 74.3 Million USD | 113.37% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 2.436% |
| LivaNova PLC | 62.53 Million USD | 115.886% |
| 908 Devices Inc. | -115.09 Million USD | 91.369% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 103.098% |
| Nemaura Medical Inc. | 9.92 Million USD | 200.091% |
| NeuroPace, Inc. | 54.33 Million USD | 118.282% |
| LENSAR, Inc. | -18.31 Million USD | 45.751% |
| Apyx Medical Corporation | -5.15 Million USD | -92.856% |
| Cutera, Inc. | 288.3 Million USD | 103.446% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 232.189% |
| BioSig Technologies, Inc. | 262 Thousand USD | 3891.603% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 77.335% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -7.99% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.707% |
| Axonics, Inc. | -77.19 Million USD | 87.131% |
| Outset Medical, Inc. | 67.67 Million USD | 114.678% |
| IRIDEX Corporation | -4.28 Million USD | -131.67% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 94.42% |
| IRadimed Corporation | -47.71 Million USD | 79.182% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -228.288% |
| INVO Bioscience, Inc. | 8.45 Million USD | 217.546% |
| Telesis Bio, Inc. | 32.63 Million USD | 130.44% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -297.021% |
| Varex Imaging Corporation | 316.9 Million USD | 103.135% |
| Quipt Home Medical Corp. | 81.73 Million USD | 112.154% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -257.081% |
| Pulmonx Corporation | -42.36 Million USD | 76.549% |
| Dynatronics Corporation | 6.2 Million USD | 260.122% |
| Modular Medical, Inc. | -8.04 Million USD | -23.526% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -131.185% |
| Semler Scientific, Inc. | -57.13 Million USD | 82.612% |
| InMode Ltd. | -135.39 Million USD | 92.663% |
| Bruker Corporation | 891.3 Million USD | 101.115% |
| Cytosorbents Corporation | 4.18 Million USD | 337.541% |
| DexCom, Inc. | 2.02 Billion USD | 100.49% |
| Align Technology, Inc. | -840.47 Million USD | 98.818% |
| Viveve Medical, Inc. | -13.81 Million USD | 28.082% |
| ZimVie Inc. | 450.41 Million USD | 102.206% |
| Movano Inc. | -5.86 Million USD | -69.349% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 92.612% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1625.351% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 600.669% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 102.784% |
| Profound Medical Corp. | -18.17 Million USD | 45.353% |
| Insulet Corporation | 798.1 Million USD | 101.245% |
| enVVeno Medical Corporation | -2.21 Million USD | -347.881% |
| Surmodics, Inc. | -12.01 Million USD | 17.313% |
| iCAD, Inc. | -21.2 Million USD | 53.161% |
| Nuwellis, Inc. | -2.81 Million USD | -252.394% |
| Biotricity, Inc. | 23.09 Million USD | 143.018% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 110.607% |
| Aethlon Medical, Inc. | -4.5 Million USD | -120.674% |
| InspireMD, Inc. | -8.04 Million USD | -23.48% |
| PAVmed Inc. | 29.08 Million USD | 134.154% |
| BIOLASE, Inc. | 11.34 Million USD | 187.571% |
| Beyond Air, Inc. | 6.22 Million USD | 259.48% |
| FONAR Corporation | -14.66 Million USD | 32.262% |
| AxoGen, Inc. | 32.26 Million USD | 130.788% |
| Vivani Medical, Inc. | 42 Thousand USD | 23752.381% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 6.793% |
| Inari Medical, Inc. | -7.16 Million USD | -38.724% |
| UFP Technologies, Inc. | 40.77 Million USD | 124.364% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 423.728% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -108.203% |
| Tenon Medical, Inc. | -1.25 Million USD | -691.554% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -30.607% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 16.705% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.448% |
| Sintx Technologies, Inc. | 905 Thousand USD | 1197.68% |
| NanoVibronix, Inc. | -3.27 Million USD | -203.051% |
| Quanterix Corporation | -132.95 Million USD | 92.528% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -257.081% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 55.582% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.318% |
| TransMedics Group, Inc. | 121.13 Million USD | 108.201% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 62.055% |
| NeuroMetrix, Inc. | -1.49 Million USD | -566.233% |
| Hyperfine, Inc. | -75.61 Million USD | 86.863% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 106.527% |
| Biomerica, Inc. | -3.38 Million USD | -193.471% |
| Bone Biologics Corporation | -3.02 Million USD | -228.226% |
| AVITA Medical, Inc. | -26.23 Million USD | 62.13% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -440.358% |
| Silk Road Medical, Inc | 64.42 Million USD | 115.42% |